Prescription drug · ANDA
Sildenafil NDC 71335-0969
Sildenafil citrate 100 mg/1 · Tablet, Film coated · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-0969-0 | 71335096900 | 15 TABLET, FILM COATED in 1 BOTTLE (71335-0969-0)Marketed from Feb 7, 2019 | |
| 71335-0969-1 | 71335096901 | 10 TABLET, FILM COATED in 1 BOTTLE (71335-0969-1)Marketed from Oct 18, 2018 | |
| 71335-0969-2 | 71335096902 | 5 TABLET, FILM COATED in 1 BOTTLE (71335-0969-2)Marketed from Dec 21, 2018 | |
| 71335-0969-3 | 71335096903 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-0969-3)Marketed from Nov 5, 2018 | |
| 71335-0969-4 | 71335096904 | 2 TABLET, FILM COATED in 1 BOTTLE (71335-0969-4)Marketed from Aug 19, 2026 | |
| 71335-0969-5 | 71335096905 | 6 TABLET, FILM COATED in 1 BOTTLE (71335-0969-5)Marketed from Aug 19, 2026 | |
| 71335-0969-6 | 71335096906 | 20 TABLET, FILM COATED in 1 BOTTLE (71335-0969-6)Marketed from Nov 28, 2018 | |
| 71335-0969-7 | 71335096907 | 4 TABLET, FILM COATED in 1 BOTTLE (71335-0969-7)Marketed from Aug 19, 2026 | |
| 71335-0969-8 | 71335096908 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-0969-8)Marketed from Aug 19, 2026 | |
| 71335-0969-9 | 71335096909 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-0969-9)Marketed from Aug 19, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sildenafil
- Generic name (nonproprietary)
- sildenafil
- Active ingredients
- Sildenafil citrate — 100 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202023
- Marketing start
- Listing expires
- Other FDA classes
- Phosphodiesterase 5 Inhibitors (Mechanism)
- Identifiers
- Product ID 71335-0969_1621566d-9ec1-4b85-a5ac-247044d9f9d1SPL ID 1621566d-9ec1-4b85-a5ac-247044d9f9d1SPL set ID 96ae6733-cef9-46cf-bf4e-5368201943bdRxCUI 314229UNII BW9B0ZE037
- Pharmacologic class
- Phosphodiesterase 5 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335096900followed by a unit qualifier and the quantityPackage 71335-0969-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil tablets are a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED). ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202023
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sildenafil | Sildenafil citrate 100 mg/1 | Tablet, Film coatedOral | NuCare Pharmaceuticals,Inc. | 68071-2985 |
| Sildenafil | Sildenafil citrate 25 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals NY LLC | 60219-1751 |
| Sildenafil | Sildenafil citrate 50 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals NY LLC | 60219-1752 |
| Sildenafil | Sildenafil citrate 100 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals NY LLC | 60219-1753 |
| Sildenafil | Sildenafil citrate 50 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-7833 |